Unlock better outcomes for patients on adjuvant CDK4/6 therapy.
Education Alert
Addressing Challenges for Patients With HR+/HER2- EBC: Managing AEs and Optimizing Adherence
1.00 CME / ABIM MOC
What's your strategy for managing patients on adjuvant CDK4/6 therapy? Expert faculty offer essential tips on managing AEs and supporting patient adherence.

 

Learn to integrate endoscopic findings, biomarkers, and patient outcomes for better IBD treatment decisions
Bridging the Gap in IBD: Patient Simulations for Enhanced Clinical Decision Making
1.00 CME / ABIM MOC
Discover how integrating endoscopic findings, biomarkers, and patient-reported outcomes can transform your treatment decisions
 

Preventing Moderate to Severe Dermatologic Adverse Events in First-Line EGFR-Mutant Advanced NSCLC Treated With Amivantamab Plus Lazertinib: Early Success of the COCOON Trial
Alexander Spira, MD, PhD, FACP, FASCO, and Randi Rabin, MPH, MSc, PA-C, discuss how proactive dermatologic adverse event management—specifically through the COCOON protocol—enhances treatment adherence, reduces toxicity, and improves quality of life for patients with EGFR-mutant non–small cell lung cancer receiving amivantamab plus lazertinib.


Featured Video
 

See how RDN improves outcomes in hypertension management
Education Alert
Long-Term Results With Renal Denervation When Guideline Recommendations Are Followed
0.50 CME / ABIM MOC
Explore how guideline-based RDN leads to better outcomes in patients with uncontrolled or resistant hypertension.

Education Alert
Optimizing Management of NF1-Associated Plexiform Neurofibromas: Expert Multidisciplinary Team Discussions
0.50 CPD
Experts discuss what you need to know to support your NF1-associated PNs patients.

時        間：114年9月27日(六) 13:15~17:00 (視訊)
地        點:   臺灣血液腫瘤藥學會YouTube頻道線上
主辦單位：臺灣血液腫瘤藥學會
協辦單位：文德藥業有限公司、台灣塩野義製藥股份有限公司
注意事項：
1.本研討會採用GOOGLE簽到，須完成簽到、課後滿意度及簽退，方能獲得學分。
2.報名開始日：即日起至9月24日
3.若有相關課程問題，請洽研討會聯絡人任冠臻小姐。E-mail: twhopa@gmail.com


---請使用海報連結掃碼填單報名---

為促進癌症免疫治療領域之跨專業合作與藥師專業參與，臺灣免疫腫瘤學會於第三屆第二次理監事會議（114年4月12日）中正式決議，擴大邀請臺灣血液腫瘤藥學會共同籌辦本年度冬季學術研討會。

本次合作旨在強化癌症免疫治療相關教育訓練，深化藥師對免疫治療藥物之認識與實務應用能力，提升整體照護品質。藉由整合醫師與藥師之專業，共同守護癌症病患的用藥安全，實現以病人為中心的全人照護目標。

學會期待透過此次協同舉辦研討會，不僅擴大藥師的參與，更促進醫療團隊之間的知識交流與臨床合作，共同迎向精準醫療與免疫治療的新時代。